Guanine nucleotides regulate binding of opiate agonists ,to membrane receptors by increasing agonist dissociation rates. The current study demonstrates that the ability of guanosine 5'-triphosphate (GTP) and its nonhydrolyzable analogue guanylyl-5'-imidodiphosphate
(Gpp(NH)p) to inhibit opiate agonist binding to rat brain membranes can be altered by two methods: by preincubating with EDTA, and by preincubating at pH 4.5. EDTA pretreatment increased the potency of Gpp(NH)p in inhibiting [3H]morphine binding by 4-fold, with little apparent change in the maximum effect of Gpp(NH)p or on levels of binding itself. The effect of EDTA pretreatment was blocked by prior incubation of membranes with excess calcium or manganese but could not be reversed by any divalent cation if the EDTA incubation was longer than 10 min. EDTA pretreatment increased the effects of GTP on dissociation rates of agonists. Pretreatment of membranes at pH 4.5 increased the ability of guanine nucleotides to regulate agonist binding by increasing the maximum effect of Gpp(NH)p from 50% to 80% inhibition of [3H]morphine binding with minor increase in potency of Gpp(NH)p.
The actions of EDTA and low pH pretreatments were additive when both were conducted on the same membranes.
These results suggest that modification of brain membranes can alter the interaction of receptors with guanine nucleotide-regulatory components which may lead to changes in post-receptor membrane events.
Guanine nucleotides play two important roles in neurotransmitter receptor function, by coupling receptors with adenylate cyclase (Rodbell, 1980) and by decreasing affinity of transmitters and agonists at receptor-binding sites (Rodbell et al., 1971; Mukherjee et al., 1975; U'Prichard and Snyder, 1978; Creese et al., 1979) . According to the model of the ternary complex as formulated first for the glucagon and P-adrenergic receptor systems, the agonist binding to a high affinity receptor site catalyzes the displacement of guanosine 5'-diphosphate (GDP) by guanosine 5'-triphosphate (GTP) on the guanine nucleotideregulatory component (the N-protein), which is then capable of activating or inhibiting adenylate cyclase depending on the nature of the receptor and N-protein system. GTP then increases dissociation rates of the agonist from the receptor binding site (Rodbell, 1980) . The action of GTP on receptor binding may be due to interactions of GTP with either the Nproteins or directly with the receptor site itself; reconstitution experiments with P-adrenergic receptors would suggest that the same N-protein mediates both functions of coupling receptors with adenylate cyclase and regulating binding of agonists (Limbird et al., 1980) . Thus, the degree of guanine nucleotide regulation of binding may provide information about the interactions of receptor-binding sites and N-proteins. Binding of opiate agonists to brain membranes and to neuroblastoma x glioma cell membranes is regulated by guanine nucleotides in a manner qualitatively similar to those of other neurotransmitter receptors (Blume, 1978a, b; Childers and Snyder, 1978, 1980) . GTP and its nonhydrolyzable analogue guanylyl-5'-imidodiphosphate (Gpp(NH)p) increase agonist dissociation rates and thereby decrease equilibrium binding; thus, the degree of regulation by guanine nucleotides can be determined either directly by measuring the decrease in 3H-agonist binding by GTP or by measuring the shift in agonist affinity in experiments displacing 3H-antagonist binding by agonists. In this way, GTP effects have been measured on multiple opiate receptor-binding sites to show that GTP has relatively more effect in inhibiting p (morphine)-binding sites than 6 (enkephalin)-binding sites in brain membranes (Chang et al., 1981) . Moreover, the ability of GTP to inhibit opiate agonist binding varies in different brain regions (Zukin and Gintzler, 1980; Zukin et al., 1980) . This information may indicate variations in the ability of opiate receptors to interact with guanine nucleotide-regulatory proteins and post-receptor membrane Vol. 4, No. 11, Nov. 1984 signaling events, but so far there have been no data to correlate these changes in guanine nucleotide sensitivity with opiate receptor function.
One important facet of the regulation of agonist binding by GTP involves the actions of cations. Sodium, which, like GTP also decreases agonist affinity (Pert and Snyder, 1974; Simon et al., 1975) , increases the effect of guanine nucleotides in regulation of binding: the actions of sodium and GTP on binding are additive (Childers and Snyder, 1980) . Divalent cations, which antagonize the effects of GTP on other receptor systems such as the cu-adrenergic receptor (Rouot et al., 1980) , appear to have little effect on guanine nucleotide actions on brain opiate receptors: divalent cations reverse the effects of GTP itself on opiate agonist binding, but this action is caused by an increase in phosphatase activity which hydrolyzes GTP, since the same ions have little effect on the actions of Gpp(NH)p (Childers and Snyder, 1980 After centrifugation at 48,000 x g for 10 min, the pellet was resuspended in 20 ml of Tris buffer, incubated at 37°C for 45 min to remove endogenous opiates (Pasternak and Snyder, 1975; Pasternak et al., 1975) , and centrifuged again at 48,000 x g for 10 min. The pellet was resuspended in fresh buffer for treatment at low pH or with EDTA as described below, centrifuged at 48,000 x g for 10 min, and resuspended in 100 vol of Tris buffer. Binding assays were conducted as previously described (Childers and Snyder, 1980) EDTA pretreatment had no effect on the inhibition of binding by sodium alone (Fig. 2, triangles) . Addition of Gpp(NH)p in the presence of sodium (Fig. 2, actions at 50 and 100 IIIM NaCl, but this may represent the fact that binding is too low at these concentrations of sodium to obtain accurate estimations of guanine nucleotide effects.
Effects of divalent cations on guanine nucleotide regulation of binding.
The finding that EDTA pretreatment increased the potency of guanine nucleotides in inhibiting opiate agonist binding suggested that divalent cations in brain membranes might play a role in regulating interaction of guanine nucleotide-regulatory sites with opiate receptors. The most direct test of this suggestion was to estimate the effects of divalent cations on the potency of guanine nucleotides in regulating binding in control (not treated with EDTA) membranes. When membranes were incubated with 200 pM manganese, magnesium, or calcium, binding of 3H-agonists was increased by 10 to 20%, as reported previously (Pasternak et al., 1975) . However, as seen in Figure 1 , the addition of these ions together to brain membranes had no significant effect on the potency of Gpp(NH)p in inhibiting
[3H]morphine binding. These results agree with the lack of effect found previously with divalent cations on Gpp(NH)p effects on binding (Childers and Snyder, 1980) and suggest either that divalent cations themselves do not affect the guanine nucleotide-regulatory components or that control membranes possess sufficient cations so that addition of exogenous cations produces no further effect.
If EDTA increases potency of guanine nucleotides by simply removing endogenous divalent cations from brain membranes, then its effects might be reversed by adding divalent cations to membranes after EDTA pretreatment.
Moreover, such reversal might exhibit a specificity for cations depending on the affinity of EDTA for different divalent cations. For three commonly used cations, EDTA has highest affinity for Mn'+, followed by Ca*+, and weakest affinity for Mg" (the pK, value for EDTA- . 4, No. 11, Nov. 1984 CONC. NaCI, mM (Table  III) . Interestingly, both EDTA and EGTA have high affinities for Ca2+ and Mn2+ (pK, for EGTA-Ca2+ is 11.0; for EGTAMn2+ it is 12.3), whereas phenanthroline has high affinity for transition metals such as Zn2+ and Ni" (pK, -8 to 9) but low affinity for Ca2+ and Mn2+ (pK, -2 to 3) (Kragten, 1978 -~-Ala enk) and were observed when both GTP and GDP were used to inhibit agonist binding (data not shown). Moreover, GTP had no effect on [3H]naloxone binding (assayed in the presence of 100 mM NaCl) in low pH-pretreated membranes.
In addition, the actions of the low pH pretreatment were not reversed by multiple wash steps at normal pH or by incubating with divalent cations or with guanine nucleotides after low pH pretreatment (data not shown). Preincubation of membranes at pH values between pH 4.5 and pH 7.7 provided an abrupt effect: the increased GTP inhibition of binding which was evident after treatment at pH 4.5 could not be detected after treatment above pH 5.0 (Table  IV) . Pretreatments below pH 4.5 caused irreversible loss of 3H-agonist binding (not shown).
Since both EDTA and low pH pretreatments increased the regulation of agonist binding by guanine nucleotides, these effects were directly compared by treating membranes by both techniques.
Membranes were first preincubated with 1 mM EDTA, then diluted with 50 mM sodium acetate, pH 4.5, and incubated at 25°C for 30 min. Results (Fig. 6) showed that the two effects were additive. In control membranes, Gpp(NH)p inhibited
[3H]morphine binding by 40% at maximum effect, with an ICsO of 1.0 pM Gpp(NH)p.
In membranes pretreated at pH 4.5, maximum inhibition was increased to 80% with an IC& of 0.8 pM Gpp(NH)p.
In membranes pretreated with 1 mM EDTA and then at low pH, the maximum inhibition effect of Gpp(NH)p remained at 80% inhibition, but the IC& was decreased to 0.3 pM Gpp(NH)p.
Therefore, the EDTA effect in increasing the potency of guanine nucleotide regulation of binding was apparent even in membranes treated at low pH to increase maximum inhibition of guanine nucleotides.
Discussion
These experiments had two principal goals: first, to examine the effects of divalent cations bound to brain membranes on the interaction of opiate receptors with guanine nucleotideregulatory components (N-proteins), and second, to modify the interaction between receptors and regulatory components so that the relationship between guanine nucleotide regulation of binding and opiate receptor function could be explored. Both of these points were explored by preincubation of rat brain membranes with EDTA to remove endogenous divalent cations. This treatment had no effect on binding when the EDTA was carefully washed away, but it significantly increased the potency of guanine nucleotides in inhibiting opiate agonist binding. Since studies with other systems revealed that divalent cations antagonized the effect of guanine nucleotides on binding regulation (Rouot et al., 1980) , the present results would tend to support such a role because removal of antagonizing cations might be expected to increase the effect of guanine nucleotides.
However, it is clear that such a simplistic explanation of the EDTA effect cannot explain the results. If removal of cations were the only effect occurring during EDTA incubation, then the effect should be reversed by adding divalent cations in excess of EDTA concentrations used. In fact, reversal of the EDTA effect by cations could only occur if the reversal took place within 10 min after addition of EDTA; longer incubation periods produced an EDTA effect whch was completely irreversible by divalent cations. On the other hand, the effect of EDTA on GTP potency was somehow related to the chelating properties of EDTA since the EDTA effect could be blocked by prior incubation of membranes with excess manganese or calcium. Moreover, this prior blockade occurred only with those cations for which EDTA has high affinities: for Ca*+ and Mn*+, the pK, values are 10.7 and 13.9, respectively, whereas the affinity of EDTA for Mg2+, which was not effective in blocking the EDTA effect, is two orders of magnitude less than that of calcium (pK, = 8.7). In addition, EGTA, with affinities for Mn2+ and Ca2+ similar to those of EDTA, mimicked the EDTA effect, whereas l,lO-phenanthroline, with low affinity for Ca2+ and Mn2+, was ineffective. The actions of EDTA also are not the result of inhibition of membrane-bound phosphatase activity, since the effect was observed if either GTP or Gpp(NH)p was utilized in binding assays. These data are consistent with the suggestion that EDTA increases the potency of guanine nucleotides in inhibiting opiate agonist binding indirectly by removing divalent cations from membrane sites. The act of cation removal may eventually produce irreversible changes in the interaction of N-proteins with receptors, perhaps by causing a conformational change in the N-proteins themselves or by denaturing an unknown membrane component that regulates the interaction of receptors with N-proteins.
This suggestion is supported not only by the irreversibility of the EDTA effect but also by the time course of the effect, which occurred within 10 min. If EDTA acted directly on divalent cations without affecting other components, the EDTA effect might be observed within seconds, since the formation of the chelate complex is extremely rapid. An effect that takes several minutes to develop is consistent with a slower process such as protein conformational changes, or physical removal of proteins or lipids from integral membrane sites. The EDTA time course may also be a function of membrane kinetics: the rate-determining step may be the penetration of EDTA into inner membrane sites. Vol. 4, No. 11, Nov. 1984 Whatever the cause of the EDTA effect on guanine nucleotide sensitivity, the result of the membrane treatment is clear. The site of EDTA effect is probably not at the receptor-binding site, since EDTA pretreatment did not produce any appreciable change in agonist binding. Instead, the effect of EDTA pretreatment was confined to the interactions of guanine nucleotides with agonist-binding sites. The actions of EDTA do not affect the maximum inhibition caused by guainine nucleotides but do increase the potency of the nucleotide effects. These results suggest that the change in the N-protein caused by EDTA is associated with an increased affinity for GTP. The decrease in the slope of Gpp(NH)p displacement curves (Fig. 1 ) may indicate the appearance of a higher affinity class of GTP-binding sites in addition to the normal micromolar affinity class, with a concomitant increase in GTP site heterogeneity. Such findings may perhaps be analogous to the classical effects of GTP on /3-adrenergic agonist binding where, by decreasing agonist affinity, GTP changes a heterogeneous agonist displacement curve containing high and low affinity sites to a homogeneous curve with only low affinity sites (Hoffman and Lefkowitz, 1980) . By analogy, EDTA pretreatment could cause the appearance of high affinity GTP-binding sites like the P-adrenergic agonist sites seen in the absence of GTP. As discussed above, such changes could result either from direct conformational changes in the N-proteins themselves or from removal (denaturation) of components which normally act to modulate the affinity of N-proteins for GTP. Based on such schemes, we attempted to reverse the EDTA effect by adding back supernatants prepared from membranes during the EDTA incubation, with the idea of reconstituting a GTP-modulating system. These experiments were not successful (S. M. Lambert and S. R. Childers, unpublished results), so that the EDTA effect remains irreversible by a variety of techniques. The interaction of guanine nucleotide-regulatory components with receptors could also be modified by low pH pretreatment of brain membranes.
Superficially, the effect of EDTA and low pH pretreatment was the same: both treatments increased the actions of guanine nucleotides on inhibiting opiate agonist binding. Moreover, the effects of low pH pretreatment were confined to guanine nucleotide interactions with agonist binding, since preincubation at pH 4.5 did not significantly affect 3H-agonist binding itself. However, the details of the effects are quite different.
Instead of increasing potency, low pH pretreatment increased the maximum effectiveness of GTP in inhibiting binding. Again, the effect of low pH pretreatment was not due to inhibition of phosphatases since the effect occurred for both GTP and Gpp(NH)p.
Moreover, like the EDTA effect, the effect of low pH pretreatment could not be reversed by washing in normal pH buffers or by cations or nucleotides. Therefore, this action was consistent with the idea that low pH causes denaturation or removal of some membrane component that regulates the interaction of receptors with guanine nucleotide-regulatory components, or alters the conformation of the N-proteins themselves in such a way as to increase the actions of guanine nucleotides.
In contrast to the effect of EDTA which increases the affinity of the system for GTP, the actions of low pH pretreatment appear to increase the overall efficacy of the regulatory component with only a small increase in the affinity of the system for GTP. Perhaps low pH pretreatment has removed a modulatory component to allow greater coupling of receptors with reguatory components, or perhaps the N-proteins themselves have changed conformation to allow more efficient coupling. Whatever the mechanism, these experiments demonstrate that membranes can be changed in ways that do not alter receptor-binding sites themselves but can significantly change the interaction between receptors and membrane-regulatory components. Unfortunately, these studies do not provide any clues as to the effects of these changes on opiate receptor function in membranes; i.e., the ability of opiate agonists to produce a postreceptor response. To explore the effects of these changes on membrane function, the next paper in this series (Childers and La Riviere, 1984) will examine the effects of modification of guanine nucleotide-regulatory components on the activities of receptor-activated and -inhibited adenylate cyclase in brain membranes.
